CN110564774B - Method for improving fixed-point modification efficiency of cell genome by using modified ssODN - Google Patents

Method for improving fixed-point modification efficiency of cell genome by using modified ssODN Download PDF

Info

Publication number
CN110564774B
CN110564774B CN201910782035.8A CN201910782035A CN110564774B CN 110564774 B CN110564774 B CN 110564774B CN 201910782035 A CN201910782035 A CN 201910782035A CN 110564774 B CN110564774 B CN 110564774B
Authority
CN
China
Prior art keywords
ssodn
modified
ths
efficiency
modification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910782035.8A
Other languages
Chinese (zh)
Other versions
CN110564774A (en
Inventor
吴珍芳
李国玲
张献伟
王豪强
李紫聪
蔡更元
刘德武
杨化强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China Agricultural University
Original Assignee
South China Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China Agricultural University filed Critical South China Agricultural University
Priority to CN201910782035.8A priority Critical patent/CN110564774B/en
Publication of CN110564774A publication Critical patent/CN110564774A/en
Application granted granted Critical
Publication of CN110564774B publication Critical patent/CN110564774B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a method for improving the fixed-point modification efficiency of a cell genome by using modified ssODN. The method is realized by the CRISPR/Cas9 system and the modified ssODN acting on the cell together. Specifically, the CRISPR/Cas9 system comprises a target gene gRNA fragment, can recognize a target gene at a fixed point, and enables the target gene to generate double-strand break, and the ssODN and the target gene are subjected to base complementary pairing at the break, so that the fixed-point modification of a genome is efficiently completed, and the modified ssODN can remarkably improve the efficiency of the fixed-point modification.

Description

Method for improving fixed-point modification efficiency of cell genome by using modified ssODN
Technical Field
The invention relates to the technical field of genetic engineering. In particular, the invention relates to a method for improving the efficiency of site-directed modification of a cellular genome using a modified ssODN.
Background
Currently, the most widely used gene editing tools mainly include Zinc finger endonuclease (ZFN), Transcription activator-like effector nuclease (TALEN), regularly Clustered short spaced palindromic repeats (CRISPR), wherein the CRISPR/Cas9 system consists of an exogenous single-stranded guide rna (sgRNA) and Cas9 protein, and the sgRNA recognizes a genome sequence by the base complementary pairing principle and guides the Cas9 protein to generate a genome Double-stranded break (DSB) at a binding target. Meanwhile, cells activate two different repair mechanisms, namely non-Homologous end joining (NHEJ) or Homologous-directed repair (HDR) in vivo, so that endogenous genes are knocked out or exogenous genes are knocked in at a fixed point. Although the efficiency of generating DSB by CRISPR/Cas9 is guaranteed to a certain extent, the efficiency of site-directed modification mediated by HDR is still quite low, so that a new way for improving the efficiency of site-directed modification of genome is urgently needed to be searched.
Disclosure of Invention
According to one aspect of the present disclosure, a method is provided for increasing the efficiency of site-directed modification of a genome of a cell using a modified ssODN by acting on the cell with the modified ssODN through a CRISPR/Cas9 system. Specifically, the CRISPR/Cas9 system comprises a target gene gRNA fragment, can recognize a target gene at a fixed point, and enables the target gene to generate double-strand break, at the break, the ssODN and the target gene are subjected to base complementary pairing to carry out homologous recombination and repair, the fixed-point modification of a genome is efficiently completed, and the modified ssODN can remarkably improve the efficiency of the fixed-point modification.
In certain embodiments, the modified ssODN comprises a BIO modification or a PHO modification or a THS modification or a THO modification or an AMN modification. Therefore, compared with unmodified ssODN, the modified ssODN can significantly improve the fixed-point modification efficiency of the cell genome by 2.8 times.
In certain embodiments, the modified ssODN is a THO modification. Thus, the efficiency of site-directed modification can be increased by 2.8-fold compared to unmodified ssODN.
In certain embodiments, the THO-modified ssODN has the gene sequence shown in SEQ ID No. 9. Thus, the efficiency of site-directed modification can be increased by 2.8-fold compared to unmodified ssODN.
In certain embodiments, the modified ssODN is a THS modification. Thus, the efficiency of site-directed modification can be increased by 2.5-fold compared to unmodified ssODN.
In certain embodiments, the THS-modified ssODN has the gene sequence shown in SEQ ID No. 8. Thus, the efficiency of site-directed modification can be increased by 2.5-fold compared to unmodified ssODN.
In certain embodiments, a method for increasing the efficiency of site-directed modification of a genome of a cell, the method comprising the steps of:
constructing a target gene CRISPR/Cas9 system expression vector;
synthesis of ssODN reporter vector;
synthesizing the modified ssODN;
screening cell lines that can express the ssODN reporter vector;
the CRISPR/Cas9 system expression vector co-transfects with the modified ssODN a cell line that can express an ssODN reporter vector;
and co-treating the screened effectively modified ssODN and the CRISPR/Cas9 system to improve the efficiency of genome site-directed modification.
Therefore, the gRNA in the expression vector of the CRISPR/Cas9 system recognizes the sequence on the ssODN report vector by the base complementary pairing principle, so that the report gene generates double-strand break, the modified ssODN and the report gene are subjected to homologous recombination and repair, the report gene is subjected to site-directed modification, an effective ssODN modification mode can be screened, the screened effectively modified ssODN and the CRISPR/Cas9 system co-process a target cell, and the genome site-directed modification efficiency of the cell can be remarkably improved.
In some embodiments, the construction of the CRISPR/Cas9 system expression vector comprises selecting a target gene, designing and synthesizing a corresponding gRNA, and constructing into a PX330 plasmid to construct a PX330-ROSA26 expression vector, wherein the gene sequence of the PX330-ROSA26 expression vector is shown in SEQ ID No: 3.
In some embodiments, the synthesis of the ssODN reporter vector comprises selecting a ssODN template sequence, and linking the selected ssODN template sequence with EGFP to form the ssODN-GFP reporter vector, wherein a sequence homologous to the target gene is inserted into the EGFP gene of the reporter vector, and the ssODN reporter gene sequence is shown in SEQ ID No: 4. Therefore, the target gene gRNA and the Cas9 protein are matched to form a CRISPR/Cas9 system, the homologous sequence of the target gene inserted between EGFP can be identified in a fixed-point manner, the double-strand break of the genome is generated, the accurate positioning and the double-strand break of the reporter gene EGFP can be realized, and the basis is provided for the subsequent realization of the fixed-point modification of the gene.
In certain embodiments, the method of increasing the efficiency of site-directed modification of a cellular genome comprises co-transfecting the obtained PX330-ROSA26 expression vector with a modified ssODN into a cell line stably expressing a reporter vector, thereby increasing the efficiency of site-directed modification of a genome.
Drawings
FIG. 1 is a schematic diagram of a ssODN-GFP reporter vector;
FIG. 2 is a graph showing the effect of different modifications of ssODN on the efficiency of site-directed modification of human cells;
FIG. 3 is a graph showing the results of different modifications of ssODN on the efficiency of site-directed hamster cell modification;
FIG. 4 is a graph showing the effect of different modifications of ssODN on the efficiency of site-directed modification of porcine-derived cells.
Detailed Description
The present disclosure is described in further detail below with reference to specific examples.
The first embodiment is as follows: method for improving human source cell genome fixed-point modification efficiency
This example was tested using human cells (293T) as a tool cell line.
1. Plasmid construction
The gRNA sequence of the porcine ROSA26 gene (the gene sequence is shown in SEQ ID No:1 and SEQ ID No: 2) was designed using an online website (https:// crispr. cos. uni-heidelberg. de/index. html) and was artificially synthesized by Huada Gene. The synthetic primer is annealed and then connected with a linearized PX330 plasmid which is cut by BpiI enzyme, and the successfully constructed plasmid is named PX330-ROSA26 (the gene sequence of the plasmid is shown as SEQ ID No: 3). Meanwhile, the ssODN-GFP report vector is designed and synthesized by Nanjing Kingsler Biotech Co., Ltd (the gene sequence of the report vector is shown as SEQ ID No: 4): a sequence homologous to ROSA26 gene, a stop codon and a BamHI enzyme cutting site are inserted in the middle of the EGFP sequence of the report vector. The unmodified ssODN and the BIO, PHO, THS, THO, AMN modified ssODN were artificially synthesized by Yinxie Jie (Shanghai) trade Co., Ltd., and the sequences are shown in SEQ ID No. 5-SEQ ID No. 10. When DSBs are generated, cells undergo homologous repair with 140nt ssODN as a homology template, EGFP repair is completed, cells can detect green fluorescence signals, and expression is terminated without homologous repair (the mode diagram of ssODN-GFP reporter vector is shown in fig. 1).
TABLE 1 primer sequence information
Figure BDA0002176903280000031
Figure BDA0002176903280000041
2. Cell recovery and culture
And opening the water bath kettle, setting the temperature to be 37 ℃, taking out the cell cryopreservation tube from the liquid nitrogen tank after the temperature is reached, and immediately putting the tube into a water bath at 37 ℃ for rapid thawing. Transferring the thawed cell suspension into a centrifugal tube in an ultraclean workbench, adding 3 times of culture solution, centrifuging at the room temperature for 5min, removing supernatant, adding culture solution containing 10% fetal calf serum to suspend and precipitate cells, diluting the cells to a required concentration, inoculating the cells into a culture dish with the diameter of 6cm, standing and culturing in a 5% CO2 incubator at the temperature of 39 ℃, changing the solution the next day, and performing subculture when the confluence degree of the cells reaches 80-90%.
3. Tool cell line screening
The ssODN-GFP reporter plasmid was digested with BglII restriction endonuclease and transfected into cells, which were then replaced with 15% FBS complete medium after 6 h. After 24h the selection was started with 400. mu.g/mL of G418, after which the G418 concentration was adjusted with the cell density. After 6d, the maintenance medium is replaced by 200 mu g/mL according to the cell growth condition, until a monoclonal cell mass is selected after 14d, and the cell mass is subcultured to a complete medium 24-well culture dish containing 15% FBS after digestion. The cells are subcultured in a 6-well plate, when the cells grow to reach 80% confluence, the frozen stock solution added with 10% DMSO is digested and stored overnight at-80 ℃, and then stored in liquid nitrogen for later use.
4. 293 cells Co-transfection of PX330-ROSA26 plasmid and ssODN Donor results
Transfection was initiated when 293 cell lines in 24-well plates grew to 60% -80%. Transfection procedures refer to Thermo fisher
Figure BDA0002176903280000051
LTX&Plus Reagent protocol, 1. mu.g/well PX330-ROSA26 plasmid and 400ng ssODN were transfected into each well. Wherein, the transfected ssODN is a blank group without modification and an experimental group modified by BIO, PHO, THS, THO and AMN. After 4-6h, the culture medium containing 10% fetal calf serum was replaced with fresh culture medium, and the percentage of the fluorescence number of the cells was measured by flow cytometry after 48 hours of continuous culture.
The results show that: the ssODN modified by THO and THS can significantly improve the efficiency of 293 cell site-directed modification, wherein the THO modification is improved by about 2 times, and the THS modification is improved by 1.8 times, and the results are shown in fig. 2.
Example two: method for improving fixed-point modification efficiency of mouse-derived cell genome
This example was tested using hamster kidney cells (BHK cells) as the tool cell line.
In the embodiment, the steps of plasmid construction, cell recovery and culture and tool cell line screening are specifically implemented according to the steps 1-3 in the first embodiment.
4. Results of cotransfection of Bingo Kidney cells with PX330-ROSA26 plasmid and ssODN Donor
Transfection was started when hamster kidney cells grew 60% -80% in 24-well plates. Transfection procedures refer to Thermo fisher
Figure BDA0002176903280000052
LTX&Plus Reagent protocol, 1. mu.g/well PX330-ROSA26 plasmid and 400ng ssODN were transfected into each well. Wherein, the transfected ssODN is a blank group without modification and an experimental group modified by BIO, PHO, THS, THO and AMN. After 4-6h, the culture medium containing 10% fetal calf serum was replaced with fresh culture medium, and the percentage of the fluorescence number of the cells was measured by flow cytometry after 48 hours of continuous culture.
The results show that: the modification of THO and THS can obviously improve the modification efficiency, wherein the THO obtains the highest modification efficiency which is about 2.3 times of that of a control group; while other modifications had no effect on the efficiency of site-directed modification, the results are shown in FIG. 3.
Example three: method for improving fixed-point modification efficiency of porcine cell genome
This example uses porcine cells (PK-15/PEF cell line) as a tool cell line for the experiments.
In the embodiment, the steps of plasmid construction, cell recovery and culture and tool cell line screening are specifically implemented according to the steps 1-3 in the first embodiment.
4. Results of Co-transfection of porcine derived cells with PX330-ROSA26 plasmid and ssODN donors
Transfection was initiated when 60% -80% of the porcine cells (PK-15/PEF cell line) in the 24-well plates grew. Transfection procedures refer to Thermo fisher
Figure BDA0002176903280000061
LTX&Plus Reagent protocol, 1. mu.g/well PX330-ROSA26 plasmid and 400ng ssODN were transfected into each well. Wherein, the transfected ssODN is a blank group without modification and an experimental group modified by BIO, PHO, THS, THO and AMN. After 4-6h, the culture medium containing 10% fetal calf serum was replaced with fresh culture medium, and the percentage of the fluorescence number of the cells was measured by flow cytometry after 48 hours of continuous culture.
The results show that: the efficiency of the THS-modified ssODN for improving PK-15 and PEF cells by about 1.1 times and 2.5 times respectively, while the efficiency of the THO-modified ssODN for improving PK-15 and PEF cells by 1.4 times and 2.8 times respectively is significantly better than that of the THS-modified ssODN, and the result is shown in FIG. 4.
Example four: the PK15 cell cotransfected by the THS modified ssODN and the CRISPR/Cas9 system can improve the site-directed modification efficiency of the ROSA26 gene
1. Plasmid construction
The gRNA sequence of the porcine ROSA26 gene (the gene sequence is shown in SEQ ID No:1 and SEQ ID No: 2) was designed using an online website (https:// crispr. cos. uni-heidelberg. de/index. html) and was artificially synthesized by Huada Gene. The synthetic primer is annealed and then connected with a linearized PX330 plasmid which is cut by BpiI enzyme, and the successfully constructed plasmid is named PX330-ROSA26 (the gene sequence of the plasmid is shown as SEQ ID No: 3).
2. Cell recovery and culture
And opening the water bath kettle, setting the temperature to be 37 ℃, taking out the cell cryopreservation tube from the liquid nitrogen tank after the temperature is reached, and immediately putting the tube into a water bath at 37 ℃ for rapid thawing. Transferring the thawed cell suspension into a centrifugal tube in an ultraclean workbench, adding 3 times of culture solution, centrifuging at the room temperature for 5min, removing supernatant, adding culture solution containing 10% fetal calf serum to suspend and precipitate cells, diluting the cells to a required concentration, inoculating the cells into a culture dish with the diameter of 6cm, standing and culturing in a 5% CO2 incubator at the temperature of 39 ℃, changing the solution the next day, and performing subculture when the confluence degree of the cells reaches 80-90%.
3. THS modified ssODN and CRISPR/Cas9 system cotransfected 293T cells
Transfection was initiated when 60% -80% of the PK15 cell lines grew in the 24-well plates. Transfection procedures refer to Thermo fisher
Figure BDA0002176903280000071
LTX&Plus Reagent protocol, 1. mu.g/well of PX330-ROSA26 plasmid and 400ng of unmodified ssODN or 400ng of THS-modified ssODN were transfected into each well, respectively. After 4-6h, the culture medium containing 10% fetal calf serum was replaced with fresh culture medium, and the percentage of the fluorescence number of the cells was measured by flow cytometry after 48 hours of continuous culture.
The results show that: the THS modified ssODN can obviously improve the site-directed modification efficiency of PK15 cells, and the THS modification efficiency can be improved by 1.5 times.
In other examples, the use of 293T cells as a tool cell line, the site-directed modification efficiency of PK15 cells was significantly improved by THS-modified ssODN, which was improved by 1.8-fold.
In other embodiments, BHK cells are used as a tool cell line, the site-directed modification efficiency of BHK cells can be significantly improved by THS-modified ssODN, and the THS modification efficiency can be improved by 2.1 times.
In other embodiments, site-directed modification is performed on the ACTB gene, and the THS-modified ssODN can significantly improve the site-directed modification efficiency by 2.3 times.
In other embodiments, the site-directed modification of GAPDH gene, the site-directed modification efficiency of THS-modified ssODN can be significantly increased by 2.7 times.
In other embodiments, where site-directed modification is performed on the SSA gene, the THS-modified ssODN can significantly improve the site-directed modification efficiency by 2.4 times.
Example five: the PK15 cell cotransfected by the ssODN modified by THO and the CRISPR/Cas9 system can improve the site-directed modification efficiency of the ROSA26 gene
1. Plasmid construction
The gRNA sequence of the porcine ROSA26 gene (the gene sequence is shown in SEQ ID No:1 and SEQ ID No: 2) was designed using an online website (https:// crispr. cos. uni-heidelberg. de/index. html) and was artificially synthesized by Huada Gene. The synthetic primer is annealed and then connected with a linearized PX330 plasmid which is cut by BpiI enzyme, and the successfully constructed plasmid is named PX330-ROSA26 (the gene sequence of the plasmid is shown as SEQ ID No: 3).
2. Cell recovery and culture
And opening the water bath kettle, setting the temperature to be 37 ℃, taking out the cell cryopreservation tube from the liquid nitrogen tank after the temperature is reached, and immediately putting the tube into a water bath at 37 ℃ for rapid thawing. Transferring the thawed cell suspension into a centrifugal tube in an ultraclean workbench, adding 3 times of culture solution, centrifuging at the room temperature for 5min, removing supernatant, adding culture solution containing 10% fetal calf serum to suspend and precipitate cells, diluting the cells to a required concentration, inoculating the cells into a culture dish with the diameter of 6cm, standing and culturing in a 5% CO2 incubator at the temperature of 39 ℃, changing the solution the next day, and performing subculture when the confluence degree of the cells reaches 80-90%.
3. THO-modified ssODN and CRISPR/Cas9 system cotransfected 293T cells
Transfection was initiated when 60% -80% of the PK15 cell lines grew in the 24-well plates. Transfection procedures refer to Thermo fisher
Figure BDA0002176903280000081
LTX&Plus Reagent protocol, 1. mu.g/well of PX330-ROSA26 plasmid and 400ng of unmodified ssODN or 400ng of THS-modified ssODN were transfected into each well, respectively. After 4-6h, the culture medium containing 10% fetal calf serum was replaced with fresh culture medium, and the percentage of the fluorescence number of the cells was measured by flow cytometry after 48 hours of continuous culture.
The results show that: the THO modified ssODN can obviously improve the site-directed modification efficiency of PK15 cells, and the THO modification efficiency can be improved by 2.2 times.
In other examples, the THO-modified ssODN can significantly improve the site-directed modification efficiency of PK15 cells by using 293T cells as a tool cell line, and the THO modification efficiency can be improved by 2.3 times.
In other embodiments, BHK cells are used as a tool cell line, the THO-modified ssODN can significantly improve the site-directed modification efficiency of BHK cells, and the THO modification efficiency can be improved by 2.5 times.
In other embodiments, site-directed modification is performed on the ACTB gene, and the THO-modified ssODN can significantly improve the site-directed modification efficiency by 2.7 times.
In other embodiments, the ssODN modified by THO can significantly improve the efficiency of site-directed modification by performing site-directed modification on GAPDH gene by 2.1 times.
In other embodiments, the SSA gene is site-directed modified, and the THO-modified ssODN can significantly improve the site-directed modification efficiency by 2.6 times.
What has been described above are merely some embodiments of the present invention. It will be apparent to those skilled in the art that various changes and modifications can be made without departing from the inventive concept herein, and it is intended to cover all such modifications and variations as fall within the scope of the invention.
Sequence listing
<110> southern China university of agriculture
<120> a method for improving the efficiency of site-directed modification of cellular genomes using modified ssODN
<130> 20190821
<160> 5
<170> SIPOSequenceListing 1.0
<210> 1
<211> 24
<212> DNA
<213> Artificial Synthesis ()
<400> 1
caccgtgaga gttatctgac cgta 24
<210> 2
<211> 24
<212> DNA
<213> Artificial Synthesis ()
<400> 2
aaactacggt cagataactc tcac 24
<210> 3
<211> 8486
<212> DNA
<213> Artificial Synthesis ()
<400> 3
tggccttttg ctggcctttt gctcacatgt gagggcctat ttcccatgat tccttcatat 60
ttgcatatac gatacaaggc tgttagagag ataattggaa ttaatttgac tgtaaacaca 120
aagatattag tacaaaatac gtgacgtaga aagtaataat ttcttgggta gtttgcagtt 180
ttaaaattat gttttaaaat ggactatcat atgcttaccg taacttgaaa gtatttcgat 240
ttcttggctt tatatatctt gtggaaagga cgaaacaccg tgagagttat ctgaccgtag 300
ttttagagct agaaatagca agttaaaata aggctagtcc gttatcaact tgaaaaagtg 360
gcaccgagtc ggtgcttttt tgttttagag ctagaaatag caagttaaaa taaggctagt 420
ccgtttttag cgcgtgcgcc aattctgcag acaaatggct ctagaggtac ccgttacata 480
acttacggta aatggcccgc ctggctgacc gcccaacgac ccccgcccat tgacgtcaat 540
agtaacgcca atagggactt tccattgacg tcaatgggtg gagtatttac ggtaaactgc 600
ccacttggca gtacatcaag tgtatcatat gccaagtacg ccccctattg acgtcaatga 660
cggtaaatgg cccgcctggc attgtgccca gtacatgacc ttatgggact ttcctacttg 720
gcagtacatc tacgtattag tcatcgctat taccatggtc gaggtgagcc ccacgttctg 780
cttcactctc cccatctccc ccccctcccc acccccaatt ttgtatttat ttatttttta 840
attattttgt gcagcgatgg gggcgggggg gggggggggg cggggcgagg ggcggggcgg 900
ggcgaggcgg agaggtgcgg cggcagccaa tcagagcggc gcgctccgaa agtttccttt 960
tatggcgagg cggcggcggc ggcggcccta taaaaagcga agcgcgcggc gggcgggagt 1020
cgctgcgcgc tgccttcgcc ccgtgccccg ctccgccgcc gcctcgcgcc gcccgccccg 1080
gctctgactg accgcgttac tcccacaggt gagcgggcgg gacggccctt ctcctccggg 1140
ctgtaattag ctgagcaaga ggtaagggtt taagggatgg ttggttggtg gggtattaat 1200
gtttaattac ctggagcacc tgcctgaaat cacttttttt caggttggac cggtgccacc 1260
atggactata aggaccacga cggagactac aaggatcatg atattgatta caaagacgat 1320
gacgataaga tggccccaaa gaagaagcgg aaggtcggta tccacggagt cccagcagcc 1380
gacaagaagt acagcatcgg cctggacatc ggcaccaact ctgtgggctg ggccgtgatc 1440
accgacgagt acaaggtgcc cagcaagaaa ttcaaggtgc tgggcaacac cgaccggcac 1500
agcatcaaga agaacctgat cggagccctg ctgttcgaca gcggcgaaac agccgaggcc 1560
acccggctga agagaaccgc cagaagaaga tacaccagac ggaagaaccg gatctgctat 1620
ctgcaagaga tcttcagcaa cgagatggcc aaggtggacg acagcttctt ccacagactg 1680
gaagagtcct tcctggtgga agaggataag aagcacgagc ggcaccccat cttcggcaac 1740
atcgtggacg aggtggccta ccacgagaag taccccacca tctaccacct gagaaagaaa 1800
ctggtggaca gcaccgacaa ggccgacctg cggctgatct atctggccct ggcccacatg 1860
atcaagttcc ggggccactt cctgatcgag ggcgacctga accccgacaa cagcgacgtg 1920
gacaagctgt tcatccagct ggtgcagacc tacaaccagc tgttcgagga aaaccccatc 1980
aacgccagcg gcgtggacgc caaggccatc ctgtctgcca gactgagcaa gagcagacgg 2040
ctggaaaatc tgatcgccca gctgcccggc gagaagaaga atggcctgtt cggaaacctg 2100
attgccctga gcctgggcct gacccccaac ttcaagagca acttcgacct ggccgaggat 2160
gccaaactgc agctgagcaa ggacacctac gacgacgacc tggacaacct gctggcccag 2220
atcggcgacc agtacgccga cctgtttctg gccgccaaga acctgtccga cgccatcctg 2280
ctgagcgaca tcctgagagt gaacaccgag atcaccaagg cccccctgag cgcctctatg 2340
atcaagagat acgacgagca ccaccaggac ctgaccctgc tgaaagctct cgtgcggcag 2400
cagctgcctg agaagtacaa agagattttc ttcgaccaga gcaagaacgg ctacgccggc 2460
tacattgacg gcggagccag ccaggaagag ttctacaagt tcatcaagcc catcctggaa 2520
aagatggacg gcaccgagga actgctcgtg aagctgaaca gagaggacct gctgcggaag 2580
cagcggacct tcgacaacgg cagcatcccc caccagatcc acctgggaga gctgcacgcc 2640
attctgcggc ggcaggaaga tttttaccca ttcctgaagg acaaccggga aaagatcgag 2700
aagatcctga ccttccgcat cccctactac gtgggccctc tggccagggg aaacagcaga 2760
ttcgcctgga tgaccagaaa gagcgaggaa accatcaccc cctggaactt cgaggaagtg 2820
gtggacaagg gcgcttccgc ccagagcttc atcgagcgga tgaccaactt cgataagaac 2880
ctgcccaacg agaaggtgct gcccaagcac agcctgctgt acgagtactt caccgtgtat 2940
aacgagctga ccaaagtgaa atacgtgacc gagggaatga gaaagcccgc cttcctgagc 3000
ggcgagcaga aaaaggccat cgtggacctg ctgttcaaga ccaaccggaa agtgaccgtg 3060
aagcagctga aagaggacta cttcaagaaa atcgagtgct tcgactccgt ggaaatctcc 3120
ggcgtggaag atcggttcaa cgcctccctg ggcacatacc acgatctgct gaaaattatc 3180
aaggacaagg acttcctgga caatgaggaa aacgaggaca ttctggaaga tatcgtgctg 3240
accctgacac tgtttgagga cagagagatg atcgaggaac ggctgaaaac ctatgcccac 3300
ctgttcgacg acaaagtgat gaagcagctg aagcggcgga gatacaccgg ctggggcagg 3360
ctgagccgga agctgatcaa cggcatccgg gacaagcagt ccggcaagac aatcctggat 3420
ttcctgaagt ccgacggctt cgccaacaga aacttcatgc agctgatcca cgacgacagc 3480
ctgaccttta aagaggacat ccagaaagcc caggtgtccg gccagggcga tagcctgcac 3540
gagcacattg ccaatctggc cggcagcccc gccattaaga agggcatcct gcagacagtg 3600
aaggtggtgg acgagctcgt gaaagtgatg ggccggcaca agcccgagaa catcgtgatc 3660
gaaatggcca gagagaacca gaccacccag aagggacaga agaacagccg cgagagaatg 3720
aagcggatcg aagagggcat caaagagctg ggcagccaga tcctgaaaga acaccccgtg 3780
gaaaacaccc agctgcagaa cgagaagctg tacctgtact acctgcagaa tgggcgggat 3840
atgtacgtgg accaggaact ggacatcaac cggctgtccg actacgatgt ggaccatatc 3900
gtgcctcaga gctttctgaa ggacgactcc atcgacaaca aggtgctgac cagaagcgac 3960
aagaaccggg gcaagagcga caacgtgccc tccgaagagg tcgtgaagaa gatgaagaac 4020
tactggcggc agctgctgaa cgccaagctg attacccaga gaaagttcga caatctgacc 4080
aaggccgaga gaggcggcct gagcgaactg gataaggccg gcttcatcaa gagacagctg 4140
gtggaaaccc ggcagatcac aaagcacgtg gcacagatcc tggactcccg gatgaacact 4200
aagtacgacg agaatgacaa gctgatccgg gaagtgaaag tgatcaccct gaagtccaag 4260
ctggtgtccg atttccggaa ggatttccag ttttacaaag tgcgcgagat caacaactac 4320
caccacgccc acgacgccta cctgaacgcc gtcgtgggaa ccgccctgat caaaaagtac 4380
cctaagctgg aaagcgagtt cgtgtacggc gactacaagg tgtacgacgt gcggaagatg 4440
atcgccaaga gcgagcagga aatcggcaag gctaccgcca agtacttctt ctacagcaac 4500
atcatgaact ttttcaagac cgagattacc ctggccaacg gcgagatccg gaagcggcct 4560
ctgatcgaga caaacggcga aaccggggag atcgtgtggg ataagggccg ggattttgcc 4620
accgtgcgga aagtgctgag catgccccaa gtgaatatcg tgaaaaagac cgaggtgcag 4680
acaggcggct tcagcaaaga gtctatcctg cccaagagga acagcgataa gctgatcgcc 4740
agaaagaagg actgggaccc taagaagtac ggcggcttcg acagccccac cgtggcctat 4800
tctgtgctgg tggtggccaa agtggaaaag ggcaagtcca agaaactgaa gagtgtgaaa 4860
gagctgctgg ggatcaccat catggaaaga agcagcttcg agaagaatcc catcgacttt 4920
ctggaagcca agggctacaa agaagtgaaa aaggacctga tcatcaagct gcctaagtac 4980
tccctgttcg agctggaaaa cggccggaag agaatgctgg cctctgccgg cgaactgcag 5040
aagggaaacg aactggccct gccctccaaa tatgtgaact tcctgtacct ggccagccac 5100
tatgagaagc tgaagggctc ccccgaggat aatgagcaga aacagctgtt tgtggaacag 5160
cacaagcact acctggacga gatcatcgag cagatcagcg agttctccaa gagagtgatc 5220
ctggccgacg ctaatctgga caaagtgctg tccgcctaca acaagcaccg ggataagccc 5280
atcagagagc aggccgagaa tatcatccac ctgtttaccc tgaccaatct gggagcccct 5340
gccgccttca agtactttga caccaccatc gaccggaaga ggtacaccag caccaaagag 5400
gtgctggacg ccaccctgat ccaccagagc atcaccggcc tgtacgagac acggatcgac 5460
ctgtctcagc tgggaggcga caaaaggccg gcggccacga aaaaggccgg ccaggcaaaa 5520
aagaaaaagt aagaattcct agagctcgct gatcagcctc gactgtgcct tctagttgcc 5580
agccatctgt tgtttgcccc tcccccgtgc cttccttgac cctggaaggt gccactccca 5640
ctgtcctttc ctaataaaat gaggaaattg catcgcattg tctgagtagg tgtcattcta 5700
ttctgggggg tggggtgggg caggacagca agggggagga ttgggaagag aatagcaggc 5760
atgctgggga gcggccgcag gaacccctag tgatggagtt ggccactccc tctctgcgcg 5820
ctcgctcgct cactgaggcc gggcgaccaa aggtcgcccg acgcccgggc tttgcccggg 5880
cggcctcagt gagcgagcga gcgcgcagct gcctgcaggg gcgcctgatg cggtattttc 5940
tccttacgca tctgtgcggt atttcacacc gcatacgtca aagcaaccat agtacgcgcc 6000
ctgtagcggc gcattaagcg cggcgggtgt ggtggttacg cgcagcgtga ccgctacact 6060
tgccagcgcc ttagcgcccg ctcctttcgc tttcttccct tcctttctcg ccacgttcgc 6120
cggctttccc cgtcaagctc taaatcgggg gctcccttta gggttccgat ttagtgcttt 6180
acggcacctc gaccccaaaa aacttgattt gggtgatggt tcacgtagtg ggccatcgcc 6240
ctgatagacg gtttttcgcc ctttgacgtt ggagtccacg ttctttaata gtggactctt 6300
gttccaaact ggaacaacac tcaactctat ctcgggctat tcttttgatt tataagggat 6360
tttgccgatt tcggtctatt ggttaaaaaa tgagctgatt taacaaaaat ttaacgcgaa 6420
ttttaacaaa atattaacgt ttacaatttt atggtgcact ctcagtacaa tctgctctga 6480
tgccgcatag ttaagccagc cccgacaccc gccaacaccc gctgacgcgc cctgacgggc 6540
ttgtctgctc ccggcatccg cttacagaca agctgtgacc gtctccggga gctgcatgtg 6600
tcagaggttt tcaccgtcat caccgaaacg cgcgagacga aagggcctcg tgatacgcct 6660
atttttatag gttaatgtca tgataataat ggtttcttag acgtcaggtg gcacttttcg 6720
gggaaatgtg cgcggaaccc ctatttgttt atttttctaa atacattcaa atatgtatcc 6780
gctcatgaga caataaccct gataaatgct tcaataatat tgaaaaagga agagtatgag 6840
tattcaacat ttccgtgtcg cccttattcc cttttttgcg gcattttgcc ttcctgtttt 6900
tgctcaccca gaaacgctgg tgaaagtaaa agatgctgaa gatcagttgg gtgcacgagt 6960
gggttacatc gaactggatc tcaacagcgg taagatcctt gagagttttc gccccgaaga 7020
acgttttcca atgatgagca cttttaaagt tctgctatgt ggcgcggtat tatcccgtat 7080
tgacgccggg caagagcaac tcggtcgccg catacactat tctcagaatg acttggttga 7140
gtactcacca gtcacagaaa agcatcttac ggatggcatg acagtaagag aattatgcag 7200
tgctgccata accatgagtg ataacactgc ggccaactta cttctgacaa cgatcggagg 7260
accgaaggag ctaaccgctt ttttgcacaa catgggggat catgtaactc gccttgatcg 7320
ttgggaaccg gagctgaatg aagccatacc aaacgacgag cgtgacacca cgatgcctgt 7380
agcaatggca acaacgttgc gcaaactatt aactggcgaa ctacttactc tagcttcccg 7440
gcaacaatta atagactgga tggaggcgga taaagttgca ggaccacttc tgcgctcggc 7500
ccttccggct ggctggttta ttgctgataa atctggagcc ggtgagcgtg gaagccgcgg 7560
tatcattgca gcactggggc cagatggtaa gccctcccgt atcgtagtta tctacacgac 7620
ggggagtcag gcaactatgg atgaacgaaa tagacagatc gctgagatag gtgcctcact 7680
gattaagcat tggtaactgt cagaccaagt ttactcatat atactttaga ttgatttaaa 7740
acttcatttt taatttaaaa ggatctaggt gaagatcctt tttgataatc tcatgaccaa 7800
aatcccttaa cgtgagtttt cgttccactg agcgtcagac cccgtagaaa agatcaaagg 7860
atcttcttga gatccttttt ttctgcgcgt aatctgctgc ttgcaaacaa aaaaaccacc 7920
gctaccagcg gtggtttgtt tgccggatca agagctacca actctttttc cgaaggtaac 7980
tggcttcagc agagcgcaga taccaaatac tgttcttcta gtgtagccgt agttaggcca 8040
ccacttcaag aactctgtag caccgcctac atacctcgct ctgctaatcc tgttaccagt 8100
ggctgctgcc agtggcgata agtcgtgtct taccgggttg gactcaagac gatagttacc 8160
ggataaggcg cagcggtcgg gctgaacggg gggttcgtgc acacagccca gcttggagcg 8220
aacgacctac accgaactga gatacctaca gcgtgagcta tgagaaagcg ccacgcttcc 8280
cgaagggaga aaggcggaca ggtatccggt aagcggcagg gtcggaacag gagagcgcac 8340
gagggagctt ccagggggaa acgcctggta tctttatagt cctgtcgggt ttcgccacct 8400
ctgacttgag cgtcgatttt tgtgatgctc gtcagggggg cggagcctat ggaaaaacgc 8460
cagcaacgcg gcctttttac ggttcc 8486
<210> 4
<211> 6155
<212> DNA
<213> Artificial Synthesis ()
<400> 4
gacggatcgg gagatctccc gatcccctat ggtgcactct cagtacaatc tgctctgatg 60
ccgcatagtt aagccagtat ctgctccctg cttgtgtgtt ggaggtcgct gagtagtgcg 120
cgagcaaaat ttaagctaca acaaggcaag gcttgaccga caattgcatg aagaatctgc 180
ttagggttag gcgttttgcg ctgcttcgcg atgtacgggc cagatatacg cgttgacatt 240
gattattgac tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata 300
tggagttccg cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc 360
cccgcccatt gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc 420
attgacgtca atgggtggag tatttacggt aaactgccca cttggcagta catcaagtgt 480
atcatatgcc aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt 540
atgcccagta catgacctta tgggactttc ctacttggca gtacatctac gtattagtca 600
tcgctattac catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg 660
actcacgggg atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc 720
aaaatcaacg ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg 780
gtaggcgtgt acggtgggag gtctatataa gcagagctct ctggctaact agagaaccca 840
ctgcttactg gcttatcgaa attaatacga ctcactatag ggagacccaa gctggctagc 900
gtttaaactt aagcttatgg tgagcaaggg cgaggagctg ttcaccgggg tggtgcccat 960
cctggtcgag ctggacggcg acgtaaacgg ccacaagttc agcgtgtccg gcgagggcga 1020
gggcgatgcc acctacggca agctgaccct gaagttcatc tgcaccaccg gcaagctgcc 1080
cgtgccctgg cccaccctcg tgaccaccct gacctacggc gtgcagtgct tcagccgcta 1140
ccccgaccac atgaagcagc acgacttctt caagtccgcc atgcccgaag gctacgtcta 1200
atgaaagctt ccttacggtc agataactct cacggatccc aggagcgcac catcttcttc 1260
aaggacgacg gcaactacaa gacccgcgcc gaggtgaagt tcgagggcga caccctggtg 1320
aaccgcatcg agctgaaggg catcgacttc aaggaggacg gcaacatcct ggggcacaag 1380
ctggagtaca actacaacag ccacaacgtc tatatcatgg ccgacaagca gaagaacggc 1440
atcaaggtga acttcaagat ccgccacaac atcgaggacg gcagcgtgca gctcgccgac 1500
cactaccagc agaacacccc catcggcgac ggccccgtgc tgctgcccga caaccactac 1560
ctgagcaccc agtccgccct gagcaaagac cccaacgaga agcgcgatca catggtcctg 1620
ctggagttcg tgaccgccgc cgggatcact ctcggcatgg acgagctgta caagtaagaa 1680
ttcctgcaga tatccagcac agtggcggcc gctcgagtct agagggcccg tttaaacccg 1740
ctgatcagcc tcgactgtgc cttctagttg ccagccatct gttgtttgcc cctcccccgt 1800
gccttccttg accctggaag gtgccactcc cactgtcctt tcctaataaa atgaggaaat 1860
tgcatcgcat tgtctgagta ggtgtcattc tattctgggg ggtggggtgg ggcaggacag 1920
caagggggag gattgggaag acaatagcag gcatgctggg gatgcggtgg gctctatggc 1980
ttctgaggcg gaaagaacca gctggggctc tagggggtat ccccacgcgc cctgtagcgg 2040
cgcattaagc gcggcgggtg tggtggttac gcgcagcgtg accgctacac ttgccagcgc 2100
cctagcgccc gctcctttcg ctttcttccc ttcctttctc gccacgttcg ccggctttcc 2160
ccgtcaagct ctaaatcggg ggctcccttt agggttccga tttagtgctt tacggcacct 2220
cgaccccaaa aaacttgatt agggtgatgg ttcacgtagt gggccatcgc cctgatagac 2280
ggtttttcgc cctttgacgt tggagtccac gttctttaat agtggactct tgttccaaac 2340
tggaacaaca ctcaacccta tctcggtcta ttcttttgat ttataaggga ttttgccgat 2400
ttcggcctat tggttaaaaa atgagctgat ttaacaaaaa tttaacgcga attaattctg 2460
tggaatgtgt gtcagttagg gtgtggaaag tccccaggct ccccagcagg cagaagtatg 2520
caaagcatgc atctcaatta gtcagcaacc aggtgtggaa agtccccagg ctccccagca 2580
ggcagaagta tgcaaagcat gcatctcaat tagtcagcaa ccatagtccc gcccctaact 2640
ccgcccatcc cgcccctaac tccgcccagt tccgcccatt ctccgcccca tggctgacta 2700
atttttttta tttatgcaga ggccgaggcc gcctctgcct ctgagctatt ccagaagtag 2760
tgaggaggct tttttggagg cctaggcttt tgcaaaaagc tcccgggagc ttgtatatcc 2820
attttcggat ctgatcaaga gacaggatga ggatcgtttc gcatgattga acaagatgga 2880
ttgcacgcag gttctccggc cgcttgggtg gagaggctat tcggctatga ctgggcacaa 2940
cagacaatcg gctgctctga tgccgccgtg ttccggctgt cagcgcaggg gcgcccggtt 3000
ctttttgtca agaccgacct gtccggtgcc ctgaatgaac tgcaggacga ggcagcgcgg 3060
ctatcgtggc tggccacgac gggcgttcct tgcgcagctg tgctcgacgt tgtcactgaa 3120
gcgggaaggg actggctgct attgggcgaa gtgccggggc aggatctcct gtcatctcac 3180
cttgctcctg ccgagaaagt atccatcatg gctgatgcaa tgcggcggct gcatacgctt 3240
gatccggcta cctgcccatt cgaccaccaa gcgaaacatc gcatcgagcg agcacgtact 3300
cggatggaag ccggtcttgt cgatcaggat gatctggacg aagagcatca ggggctcgcg 3360
ccagccgaac tgttcgccag gctcaaggcg cgcatgcccg acggcgagga tctcgtcgtg 3420
acccatggcg atgcctgctt gccgaatatc atggtggaaa atggccgctt ttctggattc 3480
atcgactgtg gccggctggg tgtggcggac cgctatcagg acatagcgtt ggctacccgt 3540
gatattgctg aagagcttgg cggcgaatgg gctgaccgct tcctcgtgct ttacggtatc 3600
gccgctcccg attcgcagcg catcgccttc tatcgccttc ttgacgagtt cttctgagcg 3660
ggactctggg gttcgaaatg accgaccaag cgacgcccaa cctgccatca cgagatttcg 3720
attccaccgc cgccttctat gaaaggttgg gcttcggaat cgttttccgg gacgccggct 3780
ggatgatcct ccagcgcggg gatctcatgc tggagttctt cgcccacccc aacttgttta 3840
ttgcagctta taatggttac aaataaagca atagcatcac aaatttcaca aataaagcat 3900
ttttttcact gcattctagt tgtggtttgt ccaaactcat caatgtatct tatcatgtct 3960
gtataccgtc gacctctagc tagagcttgg cgtaatcatg gtcatagctg tttcctgtgt 4020
gaaattgtta tccgctcaca attccacaca acatacgagc cggaagcata aagtgtaaag 4080
cctggggtgc ctaatgagtg agctaactca cattaattgc gttgcgctca ctgcccgctt 4140
tccagtcggg aaacctgtcg tgccagctgc attaatgaat cggccaacgc gcggggagag 4200
gcggtttgcg tattgggcgc tcttccgctt cctcgctcac tgactcgctg cgctcggtcg 4260
ttcggctgcg gcgagcggta tcagctcact caaaggcggt aatacggtta tccacagaat 4320
caggggataa cgcaggaaag aacatgtgag caaaaggcca gcaaaaggcc aggaaccgta 4380
aaaaggccgc gttgctggcg tttttccata ggctccgccc ccctgacgag catcacaaaa 4440
atcgacgctc aagtcagagg tggcgaaacc cgacaggact ataaagatac caggcgtttc 4500
cccctggaag ctccctcgtg cgctctcctg ttccgaccct gccgcttacc ggatacctgt 4560
ccgcctttct cccttcggga agcgtggcgc tttctcatag ctcacgctgt aggtatctca 4620
gttcggtgta ggtcgttcgc tccaagctgg gctgtgtgca cgaacccccc gttcagcccg 4680
accgctgcgc cttatccggt aactatcgtc ttgagtccaa cccggtaaga cacgacttat 4740
cgccactggc agcagccact ggtaacagga ttagcagagc gaggtatgta ggcggtgcta 4800
cagagttctt gaagtggtgg cctaactacg gctacactag aagaacagta tttggtatct 4860
gcgctctgct gaagccagtt accttcggaa aaagagttgg tagctcttga tccggcaaac 4920
aaaccaccgc tggtagcggt ttttttgttt gcaagcagca gattacgcgc agaaaaaaag 4980
gatctcaaga agatcctttg atcttttcta cggggtctga cgctcagtgg aacgaaaact 5040
cacgttaagg gattttggtc atgagattat caaaaaggat cttcacctag atccttttaa 5100
attaaaaatg aagttttaaa tcaatctaaa gtatatatga gtaaacttgg tctgacagtt 5160
accaatgctt aatcagtgag gcacctatct cagcgatctg tctatttcgt tcatccatag 5220
ttgcctgact ccccgtcgtg tagataacta cgatacggga gggcttacca tctggcccca 5280
gtgctgcaat gataccgcga gacccacgct caccggctcc agatttatca gcaataaacc 5340
agccagccgg aagggccgag cgcagaagtg gtcctgcaac tttatccgcc tccatccagt 5400
ctattaattg ttgccgggaa gctagagtaa gtagttcgcc agttaatagt ttgcgcaacg 5460
ttgttgccat tgctacaggc atcgtggtgt cacgctcgtc gtttggtatg gcttcattca 5520
gctccggttc ccaacgatca aggcgagtta catgatcccc catgttgtgc aaaaaagcgg 5580
ttagctcctt cggtcctccg atcgttgtca gaagtaagtt ggccgcagtg ttatcactca 5640
tggttatggc agcactgcat aattctctta ctgtcatgcc atccgtaaga tgcttttctg 5700
tgactggtga gtactcaacc aagtcattct gagaatagtg tatgcggcga ccgagttgct 5760
cttgcccggc gtcaatacgg gataataccg cgccacatag cagaacttta aaagtgctca 5820
tcattggaaa acgttcttcg gggcgaaaac tctcaaggat cttaccgctg ttgagatcca 5880
gttcgatgta acccactcgt gcacccaact gatcttcagc atcttttact ttcaccagcg 5940
tttctgggtg agcaaaaaca ggaaggcaaa atgccgcaaa aaagggaata agggcgacac 6000
ggaaatgttg aatactcata ctcttccttt ttcaatatta ttgaagcatt tatcagggtt 6060
attgtctcat gagcggatac atatttgaat gtatttagaa aaataaacaa ataggggttc 6120
cgcgcacatt tccccgaaaa gtgccacctg acgtc 6155
<210> 5
<211> 140
<212> DNA
<213> Artificial Synthesis ()
<400> 5
accccgacca catgaagcag cacgacttct tcaagtccgc catgcccgaa ggctacgtcc 60
aggagcgcac catcttcttc aaggacgacg gcaactacaa gacccgcgcc gaggtgaagt 120
tcgagggcga caccctggtg 140

Claims (2)

1. A method for improving the fixed-point modification efficiency of a cell genome by using a modified ssODN is characterized in that the method is realized by the joint action of a CRISPR/Cas9 system and the modified ssODN on a cell, the modified ssODN is THO modified, and the THO modified ssODN gene sequence is shown as THO-ACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTG-THS-G-THS-T-THS-G; the method can improve the site-directed modification efficiency of the porcine ROSA26 gene, wherein the sequence of an expression vector of the ROSA26 gene is shown as SEQ ID No. 3.
2. A method for improving the fixed-point modification efficiency of a cell genome by using a modified ssODN is characterized in that the method is realized by the joint action of a CRISPR/Cas9 system and the modified ssODN on a cell, the modified ssODN is a THS modification, and the gene sequence of the THS modified ssODN is shown as A-THS-C-THS-C-THS-CCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTG-THS-G-THS-T-THS-G; the method can improve the site-directed modification efficiency of the porcine ROSA26 gene, wherein the sequence of an expression vector of the ROSA26 gene is shown as SEQ ID No. 3.
CN201910782035.8A 2019-08-23 2019-08-23 Method for improving fixed-point modification efficiency of cell genome by using modified ssODN Active CN110564774B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910782035.8A CN110564774B (en) 2019-08-23 2019-08-23 Method for improving fixed-point modification efficiency of cell genome by using modified ssODN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910782035.8A CN110564774B (en) 2019-08-23 2019-08-23 Method for improving fixed-point modification efficiency of cell genome by using modified ssODN

Publications (2)

Publication Number Publication Date
CN110564774A CN110564774A (en) 2019-12-13
CN110564774B true CN110564774B (en) 2021-10-15

Family

ID=68775873

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910782035.8A Active CN110564774B (en) 2019-08-23 2019-08-23 Method for improving fixed-point modification efficiency of cell genome by using modified ssODN

Country Status (1)

Country Link
CN (1) CN110564774B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111394393B (en) * 2020-02-25 2021-10-15 华南农业大学 Inhibitor for improving genome site-specific integration efficiency and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016142719A1 (en) * 2015-03-12 2016-09-15 Genome Research Limited Biallelic genetic modification
WO2016201047A8 (en) * 2015-06-09 2017-01-12 Editas Medicine, Inc. Crispr/cas-related methods and compositions for improving transplantation
WO2017216771A3 (en) * 2016-06-17 2018-02-01 Genesis Technologies Limited Crispr-cas system, materials and methods

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016142719A1 (en) * 2015-03-12 2016-09-15 Genome Research Limited Biallelic genetic modification
WO2016201047A8 (en) * 2015-06-09 2017-01-12 Editas Medicine, Inc. Crispr/cas-related methods and compositions for improving transplantation
WO2017216771A3 (en) * 2016-06-17 2018-02-01 Genesis Technologies Limited Crispr-cas system, materials and methods

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Gene correction of HBB mutations in CD34+ hematopoietic stem cells using Cas9 mRNA and ssODN donors;Antony, Justin S;《Molecular and cellular pediatrics》;20181114;全文 *
Improved Genome Editing Efficiency and Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases;Renaud,Jean-Baptiste等;《CELL REPORTS》;20160308;摘要,第2264页第1段,RESULTS部分 *

Also Published As

Publication number Publication date
CN110564774A (en) 2019-12-13

Similar Documents

Publication Publication Date Title
KR102606929B1 (en) An engineered two-part cellular device for discovery and characterization of T-cell receptor interactions with cognate antigens
US7557200B2 (en) Superior molecular vaccine based on self-replicating RNA, suicidal DNA or naked DNA vector, that links antigen with polypeptide that promotes antigen presentation
AU2012350229B2 (en) Multiplex immuno screening assay
CN108384783B (en) A kind of circular rna loop-forming sequences and application
CN110564774B (en) Method for improving fixed-point modification efficiency of cell genome by using modified ssODN
AU2024200154A1 (en) An engineered multi-component system for identification and characterisation of T-cell receptors, T-cell antigens and their functional interaction
CN108384805B (en) Promote application of the reagent of circular rna circRNF13 expression on preparation treatment Dendritic cell drug
CN116157514A (en) Novel OMNI-59, 61, 67, 76, 79, 80, 81 and 82CRISPR nucleases
CN101608189B (en) Eukaryotic expression carrier for expressing double genes
CN107034262B (en) X-ray genetic marker probe based on synchronous light source and preparation method and application thereof
CN113088529B (en) Novel beta-glucan gene HG278 and application thereof
US20030180801A1 (en) Method for searching for gene encoding nuclear transport protein
CN108103100B (en) Eukaryotic expression vector for expressing circular RNA
CN108315349B (en) The application method of circular rna circRNF13
CN108396064B (en) Application of reagent for detecting circular RNA circRNF13 in preparation of prognosis preparation for tongue squamous cell carcinoma patient
CN108300786B (en) Application of reagent for detecting annular RNAcircRNF13 in preparation of tongue squamous cell carcinoma auxiliary diagnosis preparation
CN111690682B (en) Methods and uses for modulating skeletal muscle development
CN114134141B (en) Chimeric phenylalanine translation system with introduced unnatural amino acid and construction method thereof
CN110922484B (en) anti-EGFRvIII antibody and application thereof in disease diagnosis or treatment
CN110029127A (en) A kind of recombinant herpes simplex virus and preparation method and application carrying fluorescence Timer gene changeable colour
CN109706246B (en) Application of reagent for detecting circRNF13 by in situ hybridization in preparation of tongue squamous cell carcinoma diagnosis or patient prognosis preparation
CN114887067B (en) Brain-targeted graphene quantum dot and gene complex, preparation method and application thereof
CN108384854A (en) In situ hybridization detects application of the reagent of circular rna circRNF13 on preparing Dendritic cell patient&#39;s prognosis preparation
CN108396065A (en) In situ hybridization detects application of the reagent of circular rna circRNF13 on preparing Dendritic cell auxiliary diagnosis preparation
KR101713131B1 (en) Pharmaceutical composition for treating or preventing infection of influenza virus

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant